Brown Brothers Harriman & Co’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$634K Buy
9,905
+181
+2% +$11.9K ﹤0.01% 636
2026
Q1
$692K Buy
9,724
+4,003
+70% +$316K ﹤0.01% 516
2025
Q4
$469K Buy
5,721
+1,442
+34% +$112K ﹤0.01% 547
2025
Q3
$321K Buy
4,279
+189
+5% +$14.1K ﹤0.01% 584
2025
Q2
$303K Sell
4,090
-38
-0.9% -$2.65K ﹤0.01% 554
2025
Q1
$333K Sell
4,128
-398
-9% -$34.2K ﹤0.01% 467
2024
Q4
$354K Sell
4,526
-27
-0.6% -$2.29K ﹤0.01% 470
2024
Q3
$427K Buy
4,553
+43
+1% +$3.61K ﹤0.01% 431
2024
Q2
$351K Sell
4,510
-10
-0.2% -$816 ﹤0.01% 430
2024
Q1
$411K Sell
4,520
-362
-7% -$30.1K ﹤0.01% 391
2023
Q4
$377K Sell
4,882
-147
-3% -$10.3K ﹤0.01% 395
2023
Q3
$342K Buy
5,029
+369
+8% +$26.8K ﹤0.01% 395
2023
Q2
$379K Buy
4,660
+111
+2% +$8.86K ﹤0.01% 365
2023
Q1
$373K Buy
+4,549
New +$325K ﹤0.01% 383

Other funds holding GEHC

Brown Brothers Harriman & Co's GEHC Position: Q2 2026 in Review

Brown Brothers Harriman & Co increased its GE HealthCare (GEHC) stake by 1.9% in Q2 2026, buying an estimated $11.9K and bringing the position to 9,905 shares worth $634K. The position accounts for ﹤0.01% of the portfolio, ranked #636.

Brown Brothers Harriman & Co first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $692K in Q1 2026. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Brown Brothers Harriman & Co held 9,905 shares of GE HealthCare worth $634K as of Q2 2026.
  • Brown Brothers Harriman & Co bought 181 GE HealthCare shares in Q2 2026, an estimated $11.9K.
  • GE HealthCare made up ﹤0.01% of Brown Brothers Harriman & Co's portfolio in Q2 2026, its #636 holding.
  • Brown Brothers Harriman & Co first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Brown Brothers Harriman & Co's GE HealthCare position peaked at $692K in Q1 2026.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Brown Brothers Harriman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.